Page 2 - Exact Sciences News Today

The healthcare industry is considered to be a fairly defensive sector due to its need.

28.05.2024 - Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. William Blair ...

If there’s a common trait among effective entrepreneurs, it’s their tendency to follow unique paths to success.

1492 Capital Management LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 84,154 shares of the medical research company’s stock after selling 362 shares during […]

Johnson Financial Group Inc. boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1,637.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,299 shares of the medical research company’s stock after buying an additional 4,994 shares during […]

There is no rest for USC head coach Lindsay Gottlieb, who is preparing for a new conference, improving her roster for a national title run and fighting colon cancer in her community.

/PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the...

Award marks sixth consecutive year company has received prestigious distinction ...

Company asserts that Geneoscopy will infringe patented technology central to its Cologuard colorectal cancer screening test ...

Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The